T1	Drug 298 312	immunoglobulin
T2	Temporal 313 363	in the past 12 months before the study vaccination
T3	Reference_point 342 363	the study vaccination
R1	Has_index Arg1:T2 Arg2:T3	
R2	Has_temporal Arg1:T1 Arg2:T2	
T4	Condition 8 24	adverse reaction
T5	Condition 48 70	respiratory difficulty
T6	Procedure 32 43	vaccination
R3	AND Arg1:T4 Arg2:T6	
T7	Condition 72 82	angioedema
T8	Condition 87 98	anaphylaxis
T9	Scope 48 98	respiratory difficulty, angioedema and anaphylaxis
R4	Subsumes Arg1:T4 Arg2:T9	
T10	Condition 110 125	chronic disease
T11	Condition 130 138	diabetes
T12	Condition 101 106;118 125	Acute disease
T13	Condition 140 153	heart disease
T14	Condition 155 185	systemic arterial hypertension
*	OR T13 T14 T11
T15	Scope 130 185	diabetes, heart disease, systemic arterial hypertension
T16	Scope 101 125	Acute or chronic disease
*	OR T12 T10
R5	Subsumes Arg1:T16 Arg2:T15	
T17	Procedure 214 232	antigen injections
T18	Drug 195 208	anti-allergic
T19	Temporal 238 288	maximum timeline of 14 days before the vaccination
T20	Reference_point 273 288	the vaccination
R6	Has_index Arg1:T19 Arg2:T20	
R7	AND Arg1:T18 Arg2:T17	
R8	Has_temporal Arg1:T18 Arg2:T19	
T21	Drug 373 387	blood products
T22	Temporal 388 427	within 12 months before the vaccination
T23	Reference_point 412 427	the vaccination
R9	Has_index Arg1:T22 Arg2:T23	
R10	Has_temporal Arg1:T21 Arg2:T22	
T24	Drug 437 453	any vaccine type
T25	Temporal 454 504	within 30 days before the vaccination of the study
T26	Reference_point 476 504	the vaccination of the study
R11	Has_index Arg1:T25 Arg2:T26	
R12	Has_temporal Arg1:T24 Arg2:T25	
T27	Multiplier 507 518	Chronic use
T28	Drug 522 536	any medication
T29	Undefined_semantics 437 453	any vaccine type
T30	Undefined_semantics 522 536	any medication
R13	Has_multiplier Arg1:T28 Arg2:T27	
T31	Procedure 545 555	homeopathy
T32	Drug 578 604	nasal physiologic solution
T33	Drug 609 617	vitamins
T34	Grammar_Error 605 608	and
T35	Drug 561 573	trivial ones
T36	Undefined_semantics 561 573	trivial ones
T37	Subjective_judgement 561 573	trivial ones
*	OR T33 T32
T38	Scope 578 617	nasal physiologic solution and vitamins
R14	Subsumes Arg1:T35 Arg2:T38	
T39	Negation 538 544	except
T40	Scope 545 617	homeopathy, and trivial ones, as nasal physiologic solution and vitamins
R15	Has_negation Arg1:T40 Arg2:T39	
R16	Has_scope Arg1:T28 Arg2:T40	
T41	Drug 629 646;660 670	immunosuppressive medication
T42	Drug 650 670	cytotoxic medication
T43	Undefined_semantics 650 670	cytotoxic medication
T44	Undefined_semantics 629 646;660 670	immunosuppressive medication
*	OR T41 T42
T45	Temporal 672 692	in the last 6 months
T46	Scope 629 670	immunosuppressive or cytotoxic medication
R17	Has_temporal Arg1:T46 Arg2:T45	
T47	Parsing_Error 694 948	Individuals who have made use of this kind of medication in non-immunosuppressant doses, as nasal corticosteroid for allergic rhinitis of topic corticosteroid for non-complicated dermatitis, for more than 14 days, are allowed to be included in the study.
T48	Not_a_criteria 694 948	Individuals who have made use of this kind of medication in non-immunosuppressant doses, as nasal corticosteroid for allergic rhinitis of topic corticosteroid for non-complicated dermatitis, for more than 14 days, are allowed to be included in the study.
T49	Drug 969 999	medication under investigation
T50	Undefined_semantics 969 999	medication under investigation
T51	Temporal 1000 1038	within one year before the vaccination
T52	Reference_point 1023 1038	the vaccination
R18	Has_index Arg1:T51 Arg2:T52	
R19	Has_temporal Arg1:T49 Arg2:T51	
T53	Condition 1041 1056	Unstable asthma
T54	Qualifier 1075 1095	required urgent care
T55	Procedure 1097 1112	hospitalization
T56	Procedure 1084 1095	urgent care
T57	Procedure 1116 1126	intubation
T58	Qualifier 1075 1083;1097 1112	required hospitalization
T59	Qualifier 1075 1083;1116 1126	required intubation
*	OR T59 T58 T54
T60	Temporal 1127 1150	within the last 2 years
T61	Drug 1177 1181;1197 1211	oral corticosteroid
T62	Drug 1185 1211	intravenous corticosteroid
T63	Scope 1075 1126	required urgent care, hospitalization or intubation
T64	Qualifier 1161 1181;1197 1211	requires use of oral corticosteroid
T65	Qualifier 1161 1176;1185 1211	requires use of intravenous corticosteroid
*	OR T65 T64
T66	Scope 1161 1211	requires use of oral or intravenous corticosteroid
R21	Has_temporal Arg1:T63 Arg2:T60	
T67	Scope 1075 1150	required urgent care, hospitalization or intubation within the last 2 years
*	OR T67 T66
T68	Scope 1075 1211	required urgent care, hospitalization or intubation within the last 2 years, or which requires use of oral or intravenous corticosteroid
R20	Has_scope Arg1:T53 Arg2:T68	
T69	Condition 1214 1228	Coagulopathies
T70	Condition 1267 1286	capillary fragility
T71	Condition 1292 1299	bruises
T72	Condition 1303 1312	bleedings
T73	Qualifier 1313 1338	without justifiable cause
T74	Non-query-able 1313 1338	without justifiable cause
R22	Has_qualifier Arg1:T72 Arg2:T73	
R23	Has_qualifier Arg1:T71 Arg2:T73	
*	OR T72 T71
T75	Scope 1292 1338	bruises or bleedings without justifiable cause
R24	Has_scope Arg1:T70 Arg2:T75	
R25	AND Arg1:T69 Arg2:T70	
T76	Condition 1341 1352	Convulsions
T77	Temporal 1387 1405	before 2 years old
T78	Qualifier 1370 1385	caused by fever
T79	Negation 1354 1360	except
R26	Has_negation Arg1:T78 Arg2:T79	
T80	Condition 1380 1385	fever
R27	Has_temporal Arg1:T76 Arg2:T77	
T81	Reference_point 1394 1405	2 years old
R28	Has_qualifier Arg1:T76 Arg2:T78	
T82	Condition 1408 1427	Psychiatric disease
T83	Qualifier 1434 1474	difficults the adherence to the protocol
T84	Subjective_judgement 1434 1474	difficults the adherence to the protocol
T85	Undefined_semantics 1434 1474	difficults the adherence to the protocol
R29	Has_qualifier Arg1:T82 Arg2:T83	
T86	Condition 1484 1493	psychosis
T87	Condition 1495 1525	obsessive-compulsive disorders
T88	Condition 1527 1542	bipolar disease
T89	Qualifier 1543 1558	under treatment
T90	Procedure 1549 1558	treatment
T91	Undefined_semantics 1543 1558	under treatment
T92	Drug 1598 1605	lithium
T93	Procedure 1583 1605	treatment with lithium
T94	Condition 1610 1624	suicidal ideas
T95	Temporal 1625 1663	in the last 5 years from the inclusion
T96	Reference_point 1650 1663	the inclusion
R30	Has_qualifier Arg1:T88 Arg2:T89	
T97	Condition 1560 1605	diseases which require treatment with lithium
T98	Scope 1484 1663	psychosis, obsessive-compulsive disorders, bipolar disease under treatment, diseases which require treatment with lithium and suicidal ideas in the last 5 years from the inclusion
R31	Subsumes Arg1:T82 Arg2:T98	
R32	Has_temporal Arg1:T94 Arg2:T95	
T99	Condition 1673 1682;1720 1727	malignant disease
T100	Temporal 1666 1672	Active
T101	Condition 1701 1707	cancer
T102	Qualifier 1689 1697	any kind
R33	Has_qualifier Arg1:T101 Arg2:T102	
T103	Condition 1712 1727	treated disease
T104	Procedure 1712 1719	treated
T105	Qualifier 1712 1719	treated
T106	Qualifier 1673 1682	malignant
R34	Subsumes Arg1:T99 Arg2:T101	
R35	Has_temporal Arg1:T99 Arg2:T100	
*	OR T99 T103
T107	Subjective_judgement 1729 1781	to which the individual may relapse during the study
T108	Undefined_semantics 1729 1781	to which the individual may relapse during the study
T109	Non-query-able 1729 1781	to which the individual may relapse during the study
T110	Qualifier 1729 1764	to which the individual may relapse
T111	Temporal 1765 1781	during the study
R36	Has_temporal Arg1:T110 Arg2:T111	
T112	Reference_point 1772 1781	the study
T113	Scope 1666 1727	Active malignant (p.e. any kind of cancer) or treated disease
R37	Has_qualifier Arg1:T113 Arg2:T110	
T114	Condition 1784 1792	Asplenia
T115	Negation 1794 1804	absence of
T116	Condition 1805 1811	spleen
T117	Procedure 1805 1811;1819 1826	spleen removal
R38	Has_negation Arg1:T116 Arg2:T115	
*	OR T117 T116
T118	Scope 1794 1826	absence of spleen or its removal
R39	Subsumes Arg1:T114 Arg2:T116	
T119	Measurement 1839 1842	HIV
T120	Value 1830 1838	Positive
R40	Has_value Arg1:T119 Arg2:T120	
T121	Temporal 1843 1871	in the screening examination
T122	Reference_point 1850 1871	screening examination
T123	Condition 1890 1915	immunosuppressant disease
T124	Undefined_semantics 1890 1915	immunosuppressant disease
R41	Has_temporal Arg1:T119 Arg2:T121	
*	OR T119 T123
T125	Measurement 1927 1951	serology for C hepatitis
T126	Value 1918 1926	Positive
R42	Has_value Arg1:T125 Arg2:T126	
T127	Temporal 1952 1979	in the screening evaluation
T128	Reference_point 1959 1979	screening evaluation
R43	Has_temporal Arg1:T125 Arg2:T127	
T129	Measurement 1991 2002	Antigen HBs
T130	Value 1982 1990	Positive
R44	Has_value Arg1:T129 Arg2:T130	
T131	Temporal 2003 2030	in the screening evaluation
T132	Reference_point 2010 2030	screening evaluation
R45	Has_temporal Arg1:T129 Arg2:T131	
T133	Condition 2033 2043	Alcoholism
T134	Measurement 2045 2058	CAGE criteria
T135	Value 2033 2043	Alcoholism
R46	Has_value Arg1:T134 Arg2:T135	
R47	Subsumes Arg1:T133 Arg2:T134	
T136	Not_a_criteria 2061 2321	used for detection of abusive drinkers or alcoholic, validated in the Brazilian population with sensibility of 88% and specificity of 83%, if two or more answers, among four possible, are afirmative(Mansur and Monteiro, 1983), or according to medical decision;
T137	Condition 2323 2345	Abuse of illicit drugs
T138	Subjective_judgement 2347 2376	according to medical decision
T139	Condition 2379 2387;2402 2418	Acquired immunodeficiency
T140	Condition 2391 2418	congenital immunodeficiency
*	OR T140 T139
T141	Condition 2421 2453	Allergy to the vaccine compounds
T142	Drug 2436 2453	vaccine compounds
T143	Drug 2458 2461	egg
T144	Drug 2463 2471	neomycin
T145	Drug 2476 2483	gelatin
*	OR T143 T144 T145
T146	Scope 2458 2483	egg, neomycin and gelatin
R48	Subsumes Arg1:T142 Arg2:T146	
